Xenon Pharmaceuticals Inc. (XENE) stock
XENENasdaqPharmaceutical PreparationsFiscal year ends December 31
$38.78−0.48 (-1.22%)
Close on Nov 17, 2026Market cap $3.76BP/E –Yield –
Xenon Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Xenon Pharmaceuticals's price to book ratio was 3.3× on Nov 11, 2026, against 6.2× a year earlier. Over the last 5 years it ranged from 2.6× to 8.0×, with a median of 3.5×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 3.3× | −2.9 |
| 2025 | Dec 31, 2025 | 6.2× | +2.5 |
| 2024 | Dec 31, 2024 | 3.7× | −1.0 |
| 2023 | Dec 29, 2023 | 4.7× | +1.4 |
| 2022 | Dec 30, 2022 | 3.3× | −1.9 |
| 2021 | Dec 31, 2021 | 5.2× | +2.2 |
| 2020 | Dec 31, 2020 | 3.0× | −1.6 |
| 2019 | Dec 31, 2019 | 4.5× | +3.1 |
| 2018 | Dec 31, 2018 | 1.4× | +0.3 |
| 2017 | Dec 29, 2017 | 1.2× | −0.8 |
| 2016 | Dec 30, 2016 | 2.0× | +0.2 |
| 2015 | Dec 31, 2015 | 1.8× | – |
See a number that looks wrong?